• 1. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 4. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 5. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Isoxazoles

Introduction to 4-(2-bromoethyl)-1,2-oxazole (CAS No. 1314398-14-5)

4-(2-bromoethyl)-1,2-oxazole, identified by the Chemical Abstracts Service Number (CAS No.) 1314398-14-5, is a significant compound in the field of pharmaceutical chemistry and medicinal biology. This heterocyclic organic molecule features a unique structural framework consisting of an oxazole ring substituted with a 2-bromoethyl group. The oxazole core, characterized by its oxygen and sulfur atoms forming a five-membered aromatic-like ring, is a common motif in biologically active molecules. The presence of the 2-bromoethyl side chain introduces electrophilic and nucleophilic reactivity, making it a versatile intermediate in synthetic chemistry and drug development.

The compound has garnered attention due to its potential applications in the synthesis of novel pharmaceutical agents. Its structural features suggest utility in modulating biological pathways, particularly those involving enzyme inhibition or receptor binding. Recent advancements in medicinal chemistry have highlighted the oxazole scaffold as a key component in designing molecules with enhanced pharmacological properties. The bromine substituent on the ethyl group further enhances its reactivity, allowing for further functionalization through cross-coupling reactions such as Suzuki or Buchwald-Hartwig couplings.

In the context of contemporary research, 4-(2-bromoethyl)-1,2-oxazole has been explored as a precursor in the development of small-molecule inhibitors targeting various therapeutic areas. For instance, studies have demonstrated its role in synthesizing compounds that interact with protein kinases, which are pivotal in cancer signaling pathways. The oxazole ring's ability to stabilize transition states and its compatibility with hydrogen bonding interactions make it an attractive structural element for drug design. Additionally, the bromoethyl moiety provides a handle for introducing additional functional groups, enabling the creation of libraries of derivatives with tailored biological activities.

One notable application of this compound is in the synthesis of kinase inhibitors. Kinases are enzymes that play critical roles in cell proliferation, differentiation, and survival. Dysregulation of kinase activity is often associated with diseases such as cancer and inflammatory disorders. By leveraging the reactivity of 4-(2-bromoethyl)-1,2-oxazole, researchers have been able to develop novel inhibitors that selectively target specific kinases. These inhibitors exhibit promising preclinical activity in models of disease, highlighting their potential as therapeutic candidates.

Another area where 4-(2-bromoethyl)-1,2-oxazole has shown promise is in the development of antimicrobial agents. The rise of antibiotic-resistant pathogens necessitates the discovery of new chemical entities with unique mechanisms of action. The oxazole scaffold has been identified as a privileged structure in antimicrobial compounds due to its ability to disrupt bacterial cell wall synthesis or interfere with essential metabolic pathways. The bromoethyl group on 4-(2-bromoethyl)-1,2-oxazole allows for further derivatization to enhance binding affinity and selectivity against bacterial targets.

The synthetic utility of this compound extends beyond pharmaceutical applications. It serves as a valuable building block in organic synthesis, enabling access to complex molecules through modular construction strategies. The ease with which the bromoethyl group can be manipulated allows chemists to introduce diverse functional groups at strategic positions within the molecule. This flexibility is particularly useful in fragment-based drug design approaches, where small molecular fragments are combined to form lead compounds with optimized pharmacokinetic profiles.

Recent studies have also explored the use of 4-(2-bromoethyl)-1,2-oxazole in materials science applications. The oxazole ring's electronic properties make it suitable for incorporation into organic semiconductors and light-emitting diodes (OLEDs). Researchers have demonstrated its role in enhancing charge transport properties and luminescence efficiency in these materials. The bromoethyl substituent facilitates further chemical modifications, allowing for fine-tuning of material properties such as solubility and thermal stability.

In conclusion,4-(2-bromoethyl)-1,2-oxazole (CAS No. 1314398-14-5) is a multifaceted compound with significant potential across multiple domains of chemistry and biology. Its unique structural features make it a valuable intermediate in drug discovery programs targeting various diseases. Additionally, its synthetic versatility allows for further functionalization to create tailored molecules with enhanced biological activities. As research continues to uncover new applications for this compound,4-(2-bromoethyl)-1,2-oxazole is poised to play an increasingly important role in both academic and industrial settings.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)